Paul D. Rennert

12.9k total citations · 5 hit papers
84 papers, 10.6k citations indexed

About

Paul D. Rennert is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Paul D. Rennert has authored 84 papers receiving a total of 10.6k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Immunology, 28 papers in Oncology and 23 papers in Molecular Biology. Recurrent topics in Paul D. Rennert's work include Immune Cell Function and Interaction (19 papers), Immunotherapy and Immune Responses (18 papers) and T-cell and B-cell Immunology (18 papers). Paul D. Rennert is often cited by papers focused on Immune Cell Function and Interaction (19 papers), Immunotherapy and Immune Responses (18 papers) and T-cell and B-cell Immunology (18 papers). Paul D. Rennert collaborates with scholars based in United States, Japan and Germany. Paul D. Rennert's co-authors include Gordon J. Freeman, Jeffrey L. Browning, Kathleen M. Mahoney, Fabienne Mackay, Reina E. Mebius, Pascal Schneider, Irving L. Weissman, Yongwon Choi, Paula S. Hochman and Dan R. Littman and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Paul D. Rennert

84 papers receiving 10.5k citations

Hit Papers

Combination cancer immunother... 1995 2026 2005 2015 2015 2003 2003 1997 1995 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Combination cancer immunotherapy and new immunomodulatory targets
    2015 1.0k citations Paul D. Rennert et al. profile →
  2. An essential function for the nuclear receptor RORγt in the generation of fetal lymphoid tissue inducer cells
    2003 786 citations Paul D. Rennert et al. profile →
  3. BAFF and APRIL: A Tutorial on B Cell Survival
    2003 780 citations Paul D. Rennert, Jeffrey L. Browning et al. profile →
  4. Developing Lymph Nodes Collect CD4 + CD3 − LTβ + Cells That Can Differentiate to APC, NK Cells, and Follicular Cells but Not T or B Cells
    1997 546 citations Paul D. Rennert et al. profile →
  5. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4
    1995 507 citations Paul D. Rennert, Gary S. Gray et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul D. Rennert United States 51 6.9k 2.3k 2.0k 1.1k 926 84 10.6k
Carola G. Vinuesa Australia 54 11.2k 1.6× 2.9k 1.3× 1.7k 0.9× 957 0.9× 526 0.6× 117 14.8k
Boris Reizis United States 57 9.5k 1.4× 3.1k 1.3× 1.5k 0.8× 776 0.7× 432 0.5× 131 12.6k
Iqbal S. Grewal United States 56 7.7k 1.1× 2.0k 0.9× 2.3k 1.2× 808 0.7× 465 0.5× 125 10.8k
Ian C. M. MacLennan United Kingdom 54 8.8k 1.3× 2.2k 1.0× 1.4k 0.7× 846 0.8× 374 0.4× 99 12.0k
William C. Fanslow United States 58 9.6k 1.4× 2.3k 1.0× 2.3k 1.1× 959 0.9× 526 0.6× 108 13.1k
Eckhard R. Podack United States 64 9.0k 1.3× 3.9k 1.7× 2.1k 1.1× 992 0.9× 510 0.6× 254 14.0k
Jonathon D. Sedgwick Australia 56 10.5k 1.5× 2.0k 0.9× 2.6k 1.3× 642 0.6× 723 0.8× 98 15.0k
Nancy H. Ruddle United States 67 9.1k 1.3× 2.7k 1.2× 2.9k 1.5× 753 0.7× 937 1.0× 174 14.2k
David M. Tarlinton Australia 68 12.3k 1.8× 4.8k 2.1× 2.5k 1.2× 1.4k 1.3× 624 0.7× 183 17.0k
Michael D. Gunn United States 49 7.0k 1.0× 2.7k 1.2× 2.9k 1.4× 579 0.5× 767 0.8× 102 11.2k

Countries citing papers authored by Paul D. Rennert

Since Specialization
Citations

This map shows the geographic impact of Paul D. Rennert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Rennert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Rennert more than expected).

Fields of papers citing papers by Paul D. Rennert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Rennert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Rennert. The network helps show where Paul D. Rennert may publish in the future.

Co-authorship network of co-authors of Paul D. Rennert

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Rennert. A scholar is included among the top collaborators of Paul D. Rennert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Rennert. Paul D. Rennert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hombach, Andreas, Christine Ambrose, Roy R. Lobb, Paul D. Rennert, & Hinrich Abken. (2023). A CD19-Anti-ErbB2 scFv Engager Protein Enables CD19-Specific CAR T Cells to Eradicate ErbB2+ Solid Cancer. Cells. 12(2). 248–248. 1 indexed citations
2.
Su, Lihe, Lan Wu, Roy R. Lobb, Paul D. Rennert, & Christine Ambrose. (2022). CAR-T Engager proteins optimize anti-CD19 CAR-T cell therapies for lymphoma. OncoImmunology. 11(1). 2111904–2111904. 3 indexed citations
3.
Klesmith, Justin R., Lihe Su, Lan Wu, et al.. (2019). Retargeting CD19 Chimeric Antigen Receptor T Cells via Engineered CD19-Fusion Proteins. Molecular Pharmaceutics. 16(8). 3544–3558. 23 indexed citations
4.
Rennert, Paul D., Fay J. Dufort, Lihe Su, et al.. (2018). Abstract 2569: CAR19 T cells secreting antigen-retargeting fusion proteins have remarkable potency against diverse tumor types. Cancer Research. 78(13_Supplement). 2569–2569. 1 indexed citations
5.
Mizui, Masayuki, Hisashi Arase, Kazuhiro Suzuki, et al.. (2008). Bimodal regulation of T cell-mediated immune responses by TIM-4. International Immunology. 20(5). 695–708. 59 indexed citations
6.
Sizing, Irene, Véronique Bailly, Patricia McCoon, et al.. (2007). Epitope-Dependent Effect of Anti-Murine TIM-1 Monoclonal Antibodies on T Cell Activity and Lung Immune Responses. The Journal of Immunology. 178(4). 2249–2261. 66 indexed citations
7.
Rennert, Paul D., Takaharu Ichimura, Irene Sizing, et al.. (2006). T Cell, Ig Domain, Mucin Domain-2 Gene-Deficient Mice Reveal a Novel Mechanism for the Regulation of Th2 Immune Responses and Airway Inflammation. The Journal of Immunology. 177(7). 4311–4321. 64 indexed citations
8.
Kweon, Mi‐Na, Masafumi Yamamoto, Paul D. Rennert, et al.. (2005). Prenatal Blockage of Lymphotoxin β Receptor and TNF Receptor p55 Signaling Cascade Resulted in the Acceleration of Tissue Genesis for Isolated Lymphoid Follicles in the Large Intestine. The Journal of Immunology. 174(7). 4365–4372. 32 indexed citations
9.
Lutgens, Esther, Birgit Faber, Chris T. Evelo, et al.. (2005). Gene Profiling in Atherosclerosis Reveals a Key Role for Small Inducible Cytokines. Circulation. 111(25). 3443–3452. 81 indexed citations
10.
Martı́n, Pilar, Ricardo Villares, Sandra Rodrigues‐Mascarenhas, et al.. (2005). Control of T helper 2 cell function and allergic airway inflammation by PKCζ. Proceedings of the National Academy of Sciences. 102(28). 9866–9871. 80 indexed citations
11.
Jang, Myoung Ho, Mi–Na Kweon, Masafumi Yamamoto, et al.. (2004). Intestinal villous M cells: An antigen entry site in the mucosal epithelium. Proceedings of the National Academy of Sciences. 101(16). 6110–6115. 361 indexed citations
12.
Yamamoto, Masafumi, Mi‐Na Kweon, Paul D. Rennert, et al.. (2004). Role of Gut-Associated Lymphoreticular Tissues in Antigen-Specific Intestinal IgA Immunity. The Journal of Immunology. 173(2). 762–769. 60 indexed citations
13.
Spahn, Thomas W., Howard L. Weiner, Paul D. Rennert, et al.. (2002). Mesenteric lymph nodes are critical for the induction of high-dose oral tolerance in the absence of Peyer's patches. European Journal of Immunology. 32(4). 1109–1113. 138 indexed citations
14.
Dohi, Taeko, Paul D. Rennert, Kohtaro Fujihashi, et al.. (2001). Elimination of Colonic Patches with Lymphotoxin β Receptor-Ig Prevents Th2 Cell-Type Colitis. The Journal of Immunology. 167(5). 2781–2790. 76 indexed citations
15.
Yamamoto, Masafumi, Paul D. Rennert, Jerry R. McGhee, et al.. (2000). Alternate Mucosal Immune System: Organized Peyer’s Patches Are Not Required for IgA Responses in the Gastrointestinal Tract. The Journal of Immunology. 164(10). 5184–5191. 122 indexed citations
16.
Fougerolles, Antonin R. de, Andrew Sprague, Cheryl Nickerson‐Nutter, et al.. (2000). Regulation of inflammation by collagen-binding integrins α1β1 and α2β1 in models of hypersensitivity and arthritis. Journal of Clinical Investigation. 105(6). 721–729. 188 indexed citations
17.
Rennert, Paul D.. (1997). The IgV domain of human B7-2 (CD86) is sufficient to co-stimulate T lymphocytes and induce cytokine secretion. International Immunology. 9(6). 805–813. 33 indexed citations
18.
Kirchhoff, Frank, Hilary G. Morrison, Michael G. Murray, Paul D. Rennert, & Ronald C. Desrosiers. (1994). SIVmac Expressing Hybrid Envelope Proteins Containing HIV-1 V3 and/or C4 Sequences Is Not Competent for Replication. AIDS Research and Human Retroviruses. 10(3). 309–313. 8 indexed citations
19.
20.
Sullivan, Jack, C. William Kilpatrick, & Paul D. Rennert. (1991). Biochemical Systematics of the Peromyscus boylii Species Group. Journal of Mammalogy. 72(4). 669–680. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carola G. Vinuesa Breakdown of academic impact, for papers by Boris Reizis Breakdown of academic impact, for papers by Iqbal S. Grewal Breakdown of academic impact, for papers by Ian C. M. MacLennan Breakdown of academic impact, for papers by William C. Fanslow Breakdown of academic impact, for papers by Eckhard R. Podack Breakdown of academic impact, for papers by Jonathon D. Sedgwick Breakdown of academic impact, for papers by Nancy H. Ruddle Breakdown of academic impact, for papers by David M. Tarlinton Breakdown of academic impact, for papers by Michael D. Gunn
Rankless by CCL
2026